Skip to main content

Articles

Page 44 of 48

  1. Several DNA microarray based expression signatures for the different clinically relevant thyroid tumor entities have been described over the past few years. However, reproducibility of these signatures is gene...

    Authors: Klemens Vierlinger, Markus H Mansfeld, Oskar Koperek, Christa Nöhammer, Klaus Kaserer and Friedrich Leisch
    Citation: BMC Medical Genomics 2011 4:30
  2. Postmenopausal hormone therapy (HT) influences endogenous hormone concentrations and increases the risk of breast cancer. Gene expression profiling may reveal the mechanisms behind this relationship.

    Authors: Marit Waaseth, Karina S Olsen, Charlotta Rylander, Eiliv Lund and Vanessa Dumeaux
    Citation: BMC Medical Genomics 2011 4:29
  3. The immune contribution to cancer progression is complex and difficult to characterize. For example in tumors, immune gene expression is detected from the combination of normal, tumor and immune cells in the t...

    Authors: Trevor Clancy, Marco Pedicini, Filippo Castiglione, Daniele Santoni, Vegard Nygaard, Timothy J Lavelle, Mikael Benson and Eivind Hovig
    Citation: BMC Medical Genomics 2011 4:28
  4. Diagnostic accuracy of lymphoma, a heterogeneous cancer, is essential for patient management. Several ancillary tests including immunophenotyping, and sometimes cytogenetics and PCR are required to aid histolo...

    Authors: To Ha Loi, Anna Campain, Adam Bryant, Tim J Molloy, Mark Lutherborrow, Jennifer Turner, Yee Hwa Jean Yang and David DF Ma
    Citation: BMC Medical Genomics 2011 4:27
  5. Alterations in gene expression in peripheral blood cells have been shown to be sensitive to the presence and extent of coronary artery disease (CAD). A non-invasive blood test that could reliably assess obstru...

    Authors: Michael R Elashoff, James A Wingrove, Philip Beineke, Susan E Daniels, Whittemore G Tingley, Steven Rosenberg, Szilard Voros, William E Kraus, Geoffrey S Ginsburg, Robert S Schwartz, Stephen G Ellis, Naheem Tahirkheli, Ron Waksman, John McPherson, Alexandra J Lansky and Eric J Topol
    Citation: BMC Medical Genomics 2011 4:26
  6. Clinical laboratories are adopting array genomic hybridization as a standard clinical test. A number of whole genome array genomic hybridization platforms are available, but little is known about their compara...

    Authors: Tracy Tucker, Alexandre Montpetit, David Chai, Susanna Chan, Sébastien Chénier, Bradley P Coe, Allen Delaney, Patrice Eydoux, Wan L Lam, Sylvie Langlois, Emmanuelle Lemyre, Marco Marra, Hong Qian, Guy A Rouleau, David Vincent, Jacques L Michaud…
    Citation: BMC Medical Genomics 2011 4:25
  7. Proteomic technologies applied for profiling human biofluids and blood cells are considered to reveal new biomarkers of exposure or provide insights into novel mechanisms of adaptation.

    Authors: Freek G Bouwman, Baukje de Roos, Isabel Rubio-Aliaga, L Katie Crosley, Susan J Duthie, Claus Mayer, Graham Horgan, Abigael C Polley, Carolin Heim, Susan LM Coort, Chris T Evelo, Francis Mulholland, Ian T Johnson, Ruan M Elliott, Hannelore Daniel and Edwin CM Mariman
    Citation: BMC Medical Genomics 2011 4:24
  8. An understanding of the relation of commensal microbiota to health is essential in preventing disease. Here we studied the oral microbial composition of children (N = 74, aged 3 - 18 years) in natural transiti...

    Authors: Wim Crielaard, Egija Zaura, Annemarie A Schuller, Susan M Huse, Roy C Montijn and Bart JF Keijser
    Citation: BMC Medical Genomics 2011 4:22
  9. Copy number alterations (CNA) play a key role in cancer development and progression. Since more than one CNA can be detected in most tumors, frequently co-occurring genetic CNA may point to cooperating cancer ...

    Authors: Nitin Kumar, Hubert Rehrauer, Haoyang Cai and Michael Baudis
    Citation: BMC Medical Genomics 2011 4:21
  10. The vascular disease in-stent restenosis (ISR) is characterized by formation of neointima and adverse inward remodeling of the artery after injury by coronary stent implantation. We hypothesized that the analy...

    Authors: Santhi K Ganesh, Jungnam Joo, Kimberly Skelding, Laxmi Mehta, Gang Zheng, Kathleen O'Neill, Eric M Billings, Anna Helgadottir, Karl Andersen, Gudmundur Thorgeirsson, Thorarinn Gudnason, Nancy L Geller, Robert D Simari, David R Holmes, William W O'Neill and Elizabeth G Nabel
    Citation: BMC Medical Genomics 2011 4:20
  11. Myelodysplastic Syndromes (MDSS) are pre-leukemic disorders with increasing incident rates worldwide, but very limited treatment options. Little is known about small regulatory RNAs and how they contribute to ...

    Authors: Dominik Beck, Steve Ayers, Jianguo Wen, Miriam B Brandl, Tuan D Pham, Paul Webb, Chung-Che Chang and Xiaobo Zhou
    Citation: BMC Medical Genomics 2011 4:19
  12. Paclitaxel is a microtubule-stabilizing drug that has been commonly used in treating cancer. Due to genetic heterogeneity within patient populations, therapeutic response rates often vary. Here we used the NCI...

    Authors: Lawson Eng, Irada Ibrahim-zada, Hamdi Jarjanazi, Sevtap Savas, Mehran Meschian, Kathleen I Pritchard and Hilmi Ozcelik
    Citation: BMC Medical Genomics 2011 4:18
  13. Uric acid is the primary byproduct of purine metabolism. Hyperuricemia is associated with body mass index (BMI), sex, and multiple complex diseases including gout, hypertension (HTN), renal disease, and type 2 di...

    Authors: Bashira A Charles, Daniel Shriner, Ayo Doumatey, Guanjie Chen, Jie Zhou, Hanxia Huang, Alan Herbert, Norman P Gerry, Michael F Christman, Adebowale Adeyemo and Charles N Rotimi
    Citation: BMC Medical Genomics 2011 4:17
  14. Molecular alterations critical to development of cancer include mutations, copy number alterations (amplifications and deletions) as well as genomic rearrangements resulting in gene fusions. Massively parallel...

    Authors: Ewa Przybytkowski, Cristiano Ferrario and Mark Basik
    Citation: BMC Medical Genomics 2011 4:16
  15. In the post-genomic era, multi-faceted research on complex disorders such as autism has generated diverse types of molecular information related to its pathogenesis. The rapid accumulation of putative candidat...

    Authors: Ajay Kumar, Rachna Wadhawan, Catherine Croft Swanwick, Ravi Kollu, Saumyendra N Basu and Sharmila Banerjee-Basu
    Citation: BMC Medical Genomics 2011 4:15
  16. Genomic instability in cancer leads to abnormal genome copy number alterations (CNA) as a mechanism underlying tumorigenesis. Using microarrays and other technologies, tumor CNA are detected by comparing tumor...

    Authors: Alex Lisovich, Uma R Chandran, Maureen A Lyons-Weiler, William A LaFramboise, Ashley R Brown, Regina I Jakacki, Ian F Pollack and Robert W Sobol
    Citation: BMC Medical Genomics 2011 4:14
  17. The eMERGE (electronic MEdical Records and GEnomics) Network is an NHGRI-supported consortium of five institutions to explore the utility of DNA repositories coupled to Electronic Medical Record (EMR) systems ...

    Authors: Catherine A McCarty, Rex L Chisholm, Christopher G Chute, Iftikhar J Kullo, Gail P Jarvik, Eric B Larson, Rongling Li, Daniel R Masys, Marylyn D Ritchie, Dan M Roden, Jeffery P Struewing and Wendy A Wolf
    Citation: BMC Medical Genomics 2011 4:13
  18. Readthrough fusions across adjacent genes in the genome, or transcription-induced chimeras (TICs), have been estimated using expressed sequence tag (EST) libraries to involve 4-6% of all genes. Deep transcript...

    Authors: Serban Nacu, Wenlin Yuan, Zhengyan Kan, Deepali Bhatt, Celina Sanchez Rivers, Jeremy Stinson, Brock A Peters, Zora Modrusan, Kenneth Jung, Somasekar Seshagiri and Thomas D Wu
    Citation: BMC Medical Genomics 2011 4:11
  19. Molecular classification of tumors can be achieved by global gene expression profiling. Most machine learning classification algorithms furnish global error rates for the entire population. A few algorithms pr...

    Authors: Lee K Jones, Fei Zou, Alexander Kheifets, Konstantin Rybnikov, Damon Berry and Aik Choon Tan
    Citation: BMC Medical Genomics 2011 4:10
  20. Colon cancer has been classically described by clinicopathologic features that permit the prediction of outcome only after surgical resection and staging.

    Authors: Andre Loboda, Michael V Nebozhyn, James W Watters, Carolyne A Buser, Peter Martin Shaw, Pearl S Huang, Laura Van't Veer, Rob AEM Tollenaar, David B Jackson, Deepak Agrawal, Hongyue Dai and Timothy J Yeatman
    Citation: BMC Medical Genomics 2011 4:9
  21. The molecular pathways involved in the interstitial lung diseases (ILDs) are poorly understood. Systems biology approaches, with global expression data sets, were used to identify perturbed gene networks, to g...

    Authors: Ji-Hoon Cho, Richard Gelinas, Kai Wang, Alton Etheridge, Melissa G Piper, Kara Batte, Duaa Dakhlallah, Jennifer Price, Dan Bornman, Shile Zhang, Clay Marsh and David Galas
    Citation: BMC Medical Genomics 2011 4:8
  22. Infection with H. pylori is important in the etiology of gastric cancer. Gastric cancer is infrequent in Africa, despite high frequencies of H. pylori infection, referred to as the African enigma. Variation in en...

    Authors: Tineke E Buffart, Melanie Louw, Nicole CT van Grieken, Marianne Tijssen, Beatriz Carvalho, Bauke Ylstra, Heike Grabsch, Chris JJ Mulder, Cornelis JH van de Velde, Schalk W van der Merwe and Gerrit A Meijer
    Citation: BMC Medical Genomics 2011 4:7
  23. In cancer prognosis studies with gene expression measurements, an important goal is to construct gene signatures with predictive power. In this study, we describe the coordination among genes using the weighte...

    Authors: Shuangge Ma, Michael R Kosorok, Jian Huang and Ying Dai
    Citation: BMC Medical Genomics 2011 4:5
  24. Aortic root diameter is a clinically relevant trait due to its known relationship with the pathogenesis of aortic regurgitation and risk for aortic dissection. African Americans are an understudied population ...

    Authors: Nathan E Wineinger, Amit Patki, Kristin J Meyers, Ulrich Broeckel, Charles C Gu, DC Rao, Richard B Devereux, Donna K Arnett and Hemant K Tiwari
    Citation: BMC Medical Genomics 2011 4:4
  25. Multiple breast cancer gene expression profiles have been developed that appear to provide similar abilities to predict outcome and may outperform clinical-pathologic criteria; however, the extent to which see...

    Authors: Cheng Fan, Aleix Prat, Joel S Parker, Yufeng Liu, Lisa A Carey, Melissa A Troester and Charles M Perou
    Citation: BMC Medical Genomics 2011 4:3
  26. Tetralogy of Fallot (TOF) is the most commonly observed conotruncal congenital heart defect. Treatment of these patients has evolved dramatically in the last few decades, yet a genetic explanation is lacking f...

    Authors: Douglas C Bittel, Merlin G Butler, Nataliya Kibiryeva, Jennifer A Marshall, Jie Chen, Gary K Lofland and James E O'Brien Jr
    Citation: BMC Medical Genomics 2011 4:1
  27. The onset of birth in humans, like other apes, differs from non-primate mammals in its endocrine physiology. We hypothesize that higher primate-specific gene evolution may lead to these differences and target ...

    Authors: Jevon Plunkett, Scott Doniger, Thomas Morgan, Ritva Haataja, Mikko Hallman, Hilkka Puttonen, Ramkumar Menon, Edward Kuczynski, Errol Norwitz, Victoria Snegovskikh, Aarno Palotie, Leena Peltonen, Vineta Fellman, Emily A DeFranco, Bimal P Chaudhari, John Oates…
    Citation: BMC Medical Genomics 2010 3:62
  28. Obesity results from an imbalance between food intake and energy expenditure, which leads to an excess of adipose tissue. The excess of adipose tissue and adipocyte dysfunction associated with obesity are link...

    Authors: Sara Rodríguez-Acebes, Nuria Palacios, José I Botella-Carretero, Nuria Olea, Lorena Crespo, Roberto Peromingo, Diego Gómez-Coronado, Miguel A Lasunción, Clotilde Vázquez and Javier Martínez-Botas
    Citation: BMC Medical Genomics 2010 3:61
  29. The cDNA-mediated Annealing, extension, Selection and Ligation (DASL) assay has become a suitable gene expression profiling system for degraded RNA from paraffin-embedded tissue. We examined assay characteristics...

    Authors: Monica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, Yan W Asmann, Michael A Zschunke, Ann L Oberg, Ann E McCullough, Amylou C Dueck, Beiyun Chen, Craig S April, Eliza Wickham-Garcia, Robert B Jenkins, Julie M Cunningham, Jin Jen, Edith A Perez, Jian-Bing Fan…
    Citation: BMC Medical Genomics 2010 3:60
  30. Germline mutations in the folliculin (FLCN) gene are associated with the development of Birt-Hogg-Dubé syndrome (BHDS), a disease characterized by papular skin lesions, a high occurrence of spontaneous pneumothor...

    Authors: Jeff A Klomp, David Petillo, Natalie M Niemi, Karl J Dykema, Jindong Chen, Ximing J Yang, Annika Sääf, Peter Zickert, Markus Aly, Ulf Bergerheim, Magnus Nordenskjöld, Sophie Gad, Sophie Giraud, Yves Denoux, Laurent Yonneau, Arnaud Méjean…
    Citation: BMC Medical Genomics 2010 3:59
  31. Urothelial carcinoma (UC) can arise at any location along the urothelial tract, including the urethra, bladder, ureter, or renal pelvis. Although tumors arising in these various locations have similar morpholo...

    Authors: Zhongfa Zhang, Kyle A Furge, Ximing J Yang, Bin T Teh and Donna E Hansel
    Citation: BMC Medical Genomics 2010 3:58
  32. Genome-wide association studies give insight into the genetic basis of common diseases. An open question is whether the allele frequency distributions and ancestral vs. derived states of disease-associated all...

    Authors: Joseph Lachance
    Citation: BMC Medical Genomics 2010 3:57
  33. The nuclear transcription factor estrogen receptor alpha (ER-alpha) is the target of several antiestrogen therapeutic agents for breast cancer. However, many ER-alpha positive patients do not respond to these ...

    Authors: Jaesik Jeong, Lang Li, Yunlong Liu, Kenneth P Nephew, Tim Hui-Ming Huang and Changyu Shen
    Citation: BMC Medical Genomics 2010 3:55
  34. The ultraconserved elements (UCEs) are defined as stretches of at least 200 base pairs of human DNA that match identically with corresponding regions in the mouse and rat genomes, albeit their real significanc...

    Authors: Francisco Martínez, Sandra Monfort, Mónica Roselló, Silvestre Oltra, David Blesa, Ramiro Quiroga, Sonia Mayo and Carmen Orellana
    Citation: BMC Medical Genomics 2010 3:54
  35. The sensitivity of chronic lymphocytic leukemia (CLL) cells to current treatments, both in vitro and in vivo, relies on their ability to activate apoptotic death. CLL cells resistant to DNA damage-induced apoptos...

    Authors: Jean-Brice Marteau, Odile Rigaud, Thibaut Brugat, Nathalie Gault, Laurent Vallat, Mogens Kruhoffer, Torben F Orntoft, Florence Nguyen-Khac, Sylvie Chevillard, Hélène Merle-Beral and Jozo Delic
    Citation: BMC Medical Genomics 2010 3:53
  36. The advent of gene expression profiling was expected to dramatically improve cancer diagnosis. However, despite intensive efforts and several successful examples, the development of profile-based diagnostic sy...

    Authors: Satoru Kawarazaki, Kazuya Taniguchi, Mitsuaki Shirahata, Yoji Kukita, Manabu Kanemoto, Nobuhiro Mikuni, Nobuo Hashimoto, Susumu Miyamoto, Jun A Takahashi and Kikuya Kato
    Citation: BMC Medical Genomics 2010 3:52
  37. Despite extensive research, the details of the biological mechanisms by which cancer cells acquire motility and invasiveness are largely unknown. This study identifies an invasion associated gene signature she...

    Authors: Hoon Kim, John Watkinson, Vinay Varadan and Dimitris Anastassiou
    Citation: BMC Medical Genomics 2010 3:51
  38. Disease-specific genetic information has been increasing at rapid rates as a consequence of recent improvements and massive cost reductions in sequencing technologies. Numerous systems designed to capture and ...

    Authors: Dennis P Wall, Rimma Pivovarov, Mark Tong, Jae-Yoon Jung, Vincent A Fusaro, Todd F DeLuca and Peter J Tonellato
    Citation: BMC Medical Genomics 2010 3:50
  39. Reactive oxygen species (ROS) are known mediators of cellular damage in multiple diseases including diabetic complications. Despite its importance, no comprehensive database is currently available for the gene...

    Authors: Junguk Hur, Kelli A Sullivan, Adam D Schuyler, Yu Hong, Manjusha Pande, David J States, H V Jagadish and Eva L Feldman
    Citation: BMC Medical Genomics 2010 3:49
  40. HCV infection frequently induces chronic liver diseases. The current standard treatment for chronic hepatitis (CH) C combines pegylated interferon (IFN) and ribavirin, and is less than ideal due to undesirable...

    Authors: Yoshiki Murakami, Masami Tanaka, Hidenori Toyoda, Katsuyuki Hayashi, Masahiko Kuroda, Atsushi Tajima and Kunitada Shimotohno
    Citation: BMC Medical Genomics 2010 3:48
  41. The question of a genetic contribution to the higher prevalence and incidence of end stage kidney disease (ESKD) among African Americans (AA) remained unresolved, until recent findings using admixture mapping ...

    Authors: Liran I Shlush, Sivan Bercovici, Walter G Wasser, Guennady Yudkovsky, Alan Templeton, Dan Geiger and Karl Skorecki
    Citation: BMC Medical Genomics 2010 3:47
  42. Immunization of BALB/c mice with a recombinant adenovirus expressing Mycobacterium tuberculosis (M. tuberculosis) antigen 85A (Ad85A) protects against aerosol challenge with M. tuberculosis only when it is admini...

    Authors: Lian N Lee, Dilair Baban, Edward O Ronan, Jiannis Ragoussis, Peter CL Beverley and Elma Z Tchilian
    Citation: BMC Medical Genomics 2010 3:46
  43. The prevalence of diabetes is increasing worldwide. It has been long known that increased rates of inflammatory diseases, such as obesity (OBS), hypertension (HT) and cardiovascular diseases (CVD) are highly a...

    Authors: Jesmin, Mahbubur SM Rashid, Hasan Jamil, Raquel Hontecillas and Josep Bassaganya-Riera
    Citation: BMC Medical Genomics 2010 3:45
  44. HSP90 may be a favorable target for investigational therapy in breast cancer. In fact, the HSP90 inhibitor, 17AAG, currently has entered in phase II clinical trials as an anticancer agent in breast and other t...

    Authors: Magdalena Zajac, Gonzalo Gomez, Javier Benitez and Beatriz Martínez-Delgado
    Citation: BMC Medical Genomics 2010 3:44

Annual Journal Metrics

  • 2022 Citation Impact
    2.7 - 2-year Impact Factor
    3.2 - 5-year Impact Factor
    0.730 - SNIP (Source Normalized Impact per Paper)
    0.892 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    164 days submission to accept (Median)

    2023 Usage 
    1,335,753 downloads
    593 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal